Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | COMT | P21964 | 1/20 | 0.34 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10061787 | 0.93 | L3MBTL1 (0.45) | KDM4EATML3MBTL1MEN1RAB9A | |
| SCHEMBL17248215 | 0.93 | ATM (0.41) | KDM4EATML3MBTL1MEN1RAB9A | |
| SCHEMBL24609457 | 0.92 | KDM4E (0.42) | KDM4EATML3MBTL1MEN1RAB9A | |
| SCHEMBL12036366 | 0.92 | KMT2A (0.37) | KDM4EATML3MBTL1MEN1RAB9A | |
| SCHEMBL10027583 | 0.91 | L3MBTL1 (0.49) | KDM4EATML3MBTL1MEN1RAB9A | |
| SCHEMBL10027589 | 0.91 | MEN1 (0.44) | KDM4EATML3MBTL1MEN1RAB9A | |
| SCHEMBL10060778 | 0.90 | L3MBTL1 (0.45) | KDM4EATML3MBTL1MEN1RAB9A | |
| SCHEMBL18833213 | 0.90 | L3MBTL1 (0.44) | KDM4EATML3MBTL1MEN1RAB9A | |
| SCHEMBL10060928 | 0.90 | MEN1 (0.37) | KDM4EATML3MBTL1MEN1RAB9A | |
| SCHEMBL17248218 | 0.90 | MEN1 (0.43) | KDM4EATML3MBTL1MEN1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10361378-B2 | Organic electroluminescent device | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2019-07-23 | — | — | US | disclosed |
| EP-2933851-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL & SUMIKIN CHEM CO (JP) | 2017-05-10 | — | — | EP | disclosed |
| US-20150325796-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2015-11-12 | — | — | US | disclosed |
| US-20150325796-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2015-11-12 | — | — | US | disclosed |
| EP-2933851-A1 | ORGANIC ELECTRICAL FIELD LIGHT-EMITTING ELEMENT | Nippon Steel & Sumikin Chemical Co., Ltd. (JP) | 2015-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10361378-B2 | Organic electroluminescent device | ELF3, DDT, LEF1 | KDM4E 1228/4885ATM 3768/4885L3MBTL1 74/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.